Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 May;1(3-4):273-7.
doi: 10.1023/a:1009958510378.

Familial acromegaly: case report and review of the literature

Affiliations
Review

Familial acromegaly: case report and review of the literature

A Verloes et al. Pituitary. 1999 May.

Abstract

Familial acromegaly is an exceptional clinical entity when not associated with features of multiple endocrine neoplasia type 1 (MEN1). We report here 3 pedigrees in each of which 2 patients have been shown to develop acromegaly. In 4 patients, clinical follow-up, and biological screening allowed to confidently exclude MEN1. Absence of mutation in the MEN1 gene after direct DNA analysis in 2 pedigrees reinforces the conviction that the families do not have MEN1. In families 1 and 2, diagnosis was made at a very early age and voluminous adenomas with suprasellar expansion were already present at the time of diagnosis. We review the 20 previous reports of familial acromegaly, some of them questionable. Our 3 families, combined with some other published pedigrees, allow the delineation of a familial form of acromegaly, distinct from MEN1. Dominant inheritance with reduced, age-dependant penetrance is the most parsimonious model to explain the recurrences. Gs protein pathway could be the site of action of the gene responsible of familial acromegaly, but no data have been published to sustain or reject this hypothesis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Acta Endocrinol (Copenh). 1988 Aug;118(4):503-12 - PubMed
    1. Neurol Med Chir (Tokyo). 1990 Dec;30(13):1016-9 - PubMed
    1. Eur J Endocrinol. 1995 Oct;133(4):451-6 - PubMed
    1. Neurosurgery. 1994 Nov;35(5):952-5; discussion 955-6 - PubMed
    1. Cancer. 1989 Aug 1;64(3):741-52 - PubMed

Substances

LinkOut - more resources